DE69511392D1 - Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis - Google Patents

Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis

Info

Publication number
DE69511392D1
DE69511392D1 DE69511392T DE69511392T DE69511392D1 DE 69511392 D1 DE69511392 D1 DE 69511392D1 DE 69511392 T DE69511392 T DE 69511392T DE 69511392 T DE69511392 T DE 69511392T DE 69511392 D1 DE69511392 D1 DE 69511392D1
Authority
DE
Germany
Prior art keywords
pertussis
bordetella pertussis
components
bordetella
separated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69511392T
Other languages
English (en)
Other versions
DE69511392T2 (de
Inventor
Akihiro Suehara
Eiji Yamamoto
Shigeo Fujii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69511392D1 publication Critical patent/DE69511392D1/de
Application granted granted Critical
Publication of DE69511392T2 publication Critical patent/DE69511392T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69511392T 1994-04-28 1995-04-26 Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis Expired - Fee Related DE69511392T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9156594 1994-04-28
PCT/JP1995/000830 WO1995029934A1 (en) 1994-04-28 1995-04-26 Method of separating protective components of bordetella pertussis

Publications (2)

Publication Number Publication Date
DE69511392D1 true DE69511392D1 (de) 1999-09-16
DE69511392T2 DE69511392T2 (de) 2000-03-23

Family

ID=14030044

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69511392T Expired - Fee Related DE69511392T2 (de) 1994-04-28 1995-04-26 Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis

Country Status (12)

Country Link
US (6) US6051240A (de)
EP (1) EP0755403B1 (de)
KR (1) KR100266556B1 (de)
CN (1) CN1147259A (de)
AT (1) ATE183194T1 (de)
AU (1) AU2352595A (de)
CA (1) CA2188424A1 (de)
DE (1) DE69511392T2 (de)
DK (1) DK0755403T3 (de)
ES (1) ES2136290T3 (de)
GR (1) GR3031481T3 (de)
WO (1) WO1995029934A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6444211B2 (en) * 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
EP1233022B1 (de) * 1995-05-04 2015-12-09 Aventis Pasteur Limited Verfahren zur Herstellung von Komponenten azellulären Pertussis-Impfstoffen
US8574589B2 (en) * 2009-05-11 2013-11-05 Novartis Ag Antigen purification process for pertactin antigen
WO2011005587A1 (en) * 2009-06-24 2011-01-13 University Of Dubuque Vaccine compositions and methods of use to protect against infectious disease
CN102443572B (zh) * 2011-10-21 2012-12-19 武汉生物制品研究所有限责任公司 一种对脱毒后的百日咳疫苗抗原溶液进行纯化的方法
JP2018511655A (ja) * 2015-03-20 2018-04-26 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ボルデテラ属に対するワクチン接種における使用のための免疫原性組成物
CN114767718A (zh) * 2016-03-29 2022-07-22 里尔巴斯德研究所 突变型博德特氏菌属菌株及其使用方法
CN108570098B (zh) * 2017-12-29 2021-09-07 武汉生物制品研究所有限责任公司 一种百日咳多种抗原成分的分离纯化方法
CN110358802B (zh) * 2019-08-16 2021-06-18 长春百克生物科技股份公司 一种去除百日咳组分菌毛蛋白2/3内毒素的方法
KR20220076405A (ko) * 2020-11-30 2022-06-08 주식회사 엘지화학 알루미늄 부형제를 이용하여 다가 혼합백신 내 백일해 균 유래 엔도톡신 제거 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4729957A (en) * 1984-12-13 1988-03-08 The United States Of America As Represented By The Department Of Health And Human Services Process for manufacture of L-asparaginase from erwinia chrysanthemi
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
CA1337859C (en) * 1987-04-24 1996-01-02 Masashi Chazono Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
CY1934A (en) * 1989-11-06 1990-11-01 Smithkline Beecham Biolog Process
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IT1248735B (it) * 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
CA2123222C (en) * 1991-11-15 2001-02-27 Donald A. Dearwester Gram-negative bacterial vaccines
US6696065B1 (en) * 1995-05-04 2004-02-24 Aventis Pastuer Limited Acellular pertussis vaccines and methods of preparation thereof
EP1233022B1 (de) * 1995-05-04 2015-12-09 Aventis Pasteur Limited Verfahren zur Herstellung von Komponenten azellulären Pertussis-Impfstoffen

Also Published As

Publication number Publication date
EP0755403A1 (de) 1997-01-29
KR100266556B1 (ko) 2000-09-15
WO1995029934A1 (en) 1995-11-09
AU2352595A (en) 1995-11-29
DK0755403T3 (da) 2000-02-14
US20050180987A1 (en) 2005-08-18
GR3031481T3 (en) 2000-01-31
ES2136290T3 (es) 1999-11-16
ATE183194T1 (de) 1999-08-15
US20020119161A1 (en) 2002-08-29
EP0755403B1 (de) 1999-08-11
US20030133941A1 (en) 2003-07-17
DE69511392T2 (de) 2000-03-23
KR970702874A (ko) 1997-06-10
US6051240A (en) 2000-04-18
CN1147259A (zh) 1997-04-09
US20100055134A1 (en) 2010-03-04
US20090068228A1 (en) 2009-03-12
CA2188424A1 (en) 1995-11-09

Similar Documents

Publication Publication Date Title
DE69511392T2 (de) Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
DE59805688D1 (de) Vorrichtung und verfahren zur parallel-chromatographie
DE60129046D1 (de) Verfahren und vorrichtung zur biofiltration von flüchtigen organischen verbindungen
DE60206937D1 (de) Vorrichtung und verfahren für die trennung von analyten
DK0869134T3 (da) Fremgangsmåde til udvinding af vækstfaktorer fra mælk eller et mælkederivat
DE69720473D1 (de) Verfahren zur reinigung von nukleinsäuren
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
UA43333C2 (uk) Спосіб очищення 10-дезацетилбаккатину ііі та таксотеру
DE69512416T2 (de) Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
ATE320069T1 (de) Verfahren und vorrichtung zur trennung der ionen von metallischen elementen in wässriger lösung
SE8402861L (sv) Rening av biologiskt material
ATE156187T1 (de) Verfahren zum reinigen von hepatits-a-virus (hav), so gereinigter virus und impfstoffzusammensetzungen, die ihn enthalten
DE60233202D1 (de) Verfahren zur extrahierung, fraktionierung und reinigung mittels eines harzes mit hohem adsorptions- und eluierungsrendement, von polyphenolischen verbindungen erhalten aus ausleseabfällen von frischen gemüsen
DE60042343D1 (de) Abtrennung von fibrinogen von plasmaproteasen
ATE267771T1 (de) Verfahren zur reinigung von trichlorsilan
EP0231083A3 (en) Purification of pertussis antigens
DE59108071D1 (de) Verfahren zur reinigung von abgasen, insbesondere aus abfallverbrennungsanlagen
DE60127144D1 (de) Verfahren zur reinigung von milchsäure auf industrieller basis
TH20014A (th) วิธีการแยกส่วนประกอบป้องกันโรคไอกรนของ Bordetella pertussis
ATE381577T1 (de) Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma
ATE420951T1 (de) Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen
DE60316835D1 (de) Entfernung von verunreinigungen aus einem verunreinigten gas- oder dampfstrom
ATE297385T1 (de) Verfahren zur reinigung von 2-chlor-5- chlormethylthiazol
ATE52937T1 (de) Verfahren zur trennung von wasserstoffisotopen.
DE59903651D1 (de) Verfahren zur herstellung von [15 o]butanol und vorrichtung zur durchführung des verfahrens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee